By Britain Eakin (November 23, 2022, 5:55 PM EST) — A Delaware federal jury has determined that some of AngioDynamics’ implantable port products infringed medical device maker C.R. Bard’s patents, with the company saying in a U.S. Securities and Exchange Commission report Wednesday that it “strongly disagrees” with the verdict….